NF-κB-mediated repression of growth arrest- and DNA-damage-inducible proteins 45α and γ is essential for cancer cell survival

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 37, 2004, Pages 13618-13623

  Zerbini, Luiz F ^a   Wang, Yihong ^a   Czibere, Akos ^a   Correa, Ricardo G ^c   Cho, Je Yoel ^a,d   Ijiri, Kosei ^a   Wei, Wanjang ^a   Joseph, Marie ^a   Gu, Xuesong ^a   Grall, Franck ^a   Goldring, Mary B ^a   Zhou, Jin Rhong ^b   Libermann, Towia A ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d Kyungpook National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN GADD45 ALPHA; PROTEIN GADD45 GAMMA; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INACTIVATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; DNA DAMAGE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS; NF-KAPPA B; PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION;

EID: 4544348172     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0402069101     Document Type: Article

References (29)

1. Li, Q. & Verma, I. M. (2002) Nat. Rev. Immunol. 2, 725-734.
2. Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. (2002) Nat. Rev. Cancer 2, 301-310.
3. Zerbini, L. F., Wang. Y., Cho, J. Y. & Libermann, T. A. (2003) Cancer Res. 63, 2206-2215.
4. Chauhan, D., Uchiyama, H., Akbarali, Y., Urashima, M., Yamamoto, K., Libermann, T. A. & Andersen, K. C. (1996) Blood 87, 1104-1112.
5. Oya, M., Takayanagi, A., Horiguchi, A., Mizuno, R., Ohtsubo, M., Marumo, K., Shimizu, N. & Murai, M. (2003) Carcinogenesis 24, 377-384.
6. Baldwin, A. S. (2001) J. Clin. Invest. 107, 241-246.
7. Tournier, C.,Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A. & Davis, R. J. (2000) Science 288, 870-874.
8. Verheij, M., Bose, R., Lin, X. H., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., et al. (1996) Nature 380, 75-79.
9. Tang, G., Minemoto, Y., Dibling, B., Purcell, N. H., Li, Z., Karin, M. & Lin, A. (2001) Nature 414, 313-317.
10. Hall, P. A., Kearsey, J. M., Coates, P. J., Norman, D. G., Warbrick, E. & Cox, L. S. (1995) Oncogens 10, 2427-2433.
11. Chen, I. T., Akamatsu, M., Smith, M. L., Lung, F. D., Duba, D., Roller, P. P., Fornace, A. J., Jr., & O'Connor, P. M. (1996) Oncogene 12, 595-607.
12. De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D. U., Jin, R., Jones, J., Cong, R. & Franzoso, G. (2001) Nature 15, 308-313.
13. Amanullah, A., Azam, N., Balliet, A., Hollander. C., Hoffman, B., Fornace, A. J., Jr., & Liebermann, D. (2003) Nature 424, 741.
14. Mita, H., Tsutsui, J., Takekawa, M., Witten, E. A. & Saito, H. (2002) Mol. Cell. Biol. 22, 4544-4555.
15. Sluss, H. K., Barrett, T., Derijard, B. & Davis, R. J. (1994) Mol. Cell. Biol. 14, 8376-8384.
16. Bondeson, J., Brennan, F., Foxwell, B. & Feldmann, M. (2000) J. Rheumatol. 27, 2078-2089.
17. Zhou, J. R., Yu, L., Zhong. Y., Nassr, R. L., Franke, A. A., Gaston, S. M. & Blackburn, G. L. (2002) Prostate 53, 143-153.
18. Tiscornia, G., Singer, O., Ikawa, M. & Verma, I. M. (2003) Proc. Natl Acad. Sci. USA 100, 1844-1848.
19. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M. & Trono, D. (1996) Science 272, 263-267.
20. Pfeifer, A. & Verma, I. M. (2001) Annu. Rev. Genomics Hum. Genet. 2, 177-211.
21. Takekaw, M. & Saito, H. (1998) Cell 95, 521-530.
22. Jin, S., Tong, T., Fan, W., Fan, F., Antinore, M. J., Zhu, X., Mazzacurati, L., Li, X., Petrik, K. L., Rajasekaran, B., et al. (2002) Oncogene 21, 8696-8704.
23. Barsyte-Lovejoy, D., Mao, D. Y. & Penn, L. Z. (2004) Oncogene 23, 3481-3486.
24. Harki, D. P., Bean, J. M., Miklos, D., Song, Y. H., Truong, V. B., Englert, C., Christians, F. C., Ellisen, L. W., Maheswaran, S., Oliner, J. D. & Haber, D. A. (1998) Cell 97, 575-586.
25. Lu, B., Yu, H., Chow, C., Li, B., Zheng, W., Davis, R. J. & Flavell, R. A. (2001) Immunity 14, 583-590.
26. Tran, H., Brunet, A., Grenier, J. M., Datta, S. R., Fornace, A. J., Jr., DiStefano, P. S., Chiang, L. W. & Greenberg, M. E. (2002) Science 29, 6530-6534.
27. Vairapandi, M, Balliet, A. G., Hoffman, B. & Liebermann, D. A. (2002) J. Cell. Physiol. 192, 327-338.
28. Fornace, A. J., Jr., Jackman, J., Hollander, M. C., Hoffman-Liebermann, B. & Liebermann, D. A. (1992) Ann. N.Y. Acad. Sci. 663, 139-153.
29. Kyriakis, J. M. (2001) Nature 414, 265-266.